Rhodopsin gene mutation analysis in Iranian patients with autosomal dominant retinitis pigmentosa.
Genotype–phenotype correlation
Mutation
Retinitis pigmentosa
Rhodopsin
Journal
International ophthalmology
ISSN: 1573-2630
Titre abrégé: Int Ophthalmol
Pays: Netherlands
ID NLM: 7904294
Informations de publication
Date de publication:
Nov 2019
Nov 2019
Historique:
received:
09
07
2018
accepted:
01
04
2019
pubmed:
12
4
2019
medline:
19
3
2020
entrez:
12
4
2019
Statut:
ppublish
Résumé
Retinitis pigmentosa (RP) is the most common hereditary retinal degeneration and an important cause of visual disability worldwide. Rhodopsin gene is one of the most important genes implicated in autosomal dominant RP (ADRP). In this study, we investigated rhodopsin gene mutations in Iranian patients with ADRP. Twenty-one patients from 21 unrelated families with a total of 51 affected members were enrolled in this study. After complete history taking, ophthalmic examination and genetic counseling, peripheral blood samples were obtained. Following genomic DNA extraction, all five exons and intron-exon boundaries of RHO gene were sequenced using Sanger method. Interpretation of detected variants was carried out using appropriate databases and bioinformatic tools. Novel variants were screened in 150 unrelated healthy subjects. Results of direct sequencing revealed that five of 21 patients (23.8%) had mutation in the rhodopsin gene. Two of them had previously identified p.P347L mutation, and three had novel variants including p.L95P, p.R177K and p.N310K. None of these novel variants were detected in healthy controls. The p.L95P variant was associated with predominantly inferior retinal involvement. Our study showed that mutations of the rhodopsin gene are relatively frequent in Iranian patients with ADRP and could be considered in further researches in the future. The novel p.L95P variant may be associated with a specific pattern of retinal degeneration in this population.
Identifiants
pubmed: 30972525
doi: 10.1007/s10792-019-01099-4
pii: 10.1007/s10792-019-01099-4
doi:
Substances chimiques
DNA
9007-49-2
Rhodopsin
9009-81-8
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
2523-2531Références
Genet Med. 2008 Apr;10(4):294-300
pubmed: 18414213
Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):7103-8
pubmed: 9618546
Invest Ophthalmol Vis Sci. 2008 Apr;49(4):1580-90
pubmed: 18385078
Invest Ophthalmol Vis Sci. 1996 Apr;37(5):775-82
pubmed: 8603862
Invest Ophthalmol Vis Sci. 2010 Jul;51(7):3687-700
pubmed: 20164459
Hum Genet. 2014 Oct;133(10):1255-71
pubmed: 24938718
Mol Vis. 2007 Jun 29;13:1038-44
pubmed: 17653048
Br J Ophthalmol. 2006 Aug;90(8):1060-6
pubmed: 16707518
Mol Vis. 2011;17:844-53
pubmed: 21677794
J Med Genet. 2005 Jul;42(7):e47
pubmed: 15994872
J Med Genet. 1998 Jan;35(1):1-5
pubmed: 9475085
Hum Mutat. 2001;17(1):42-51
pubmed: 11139241
Mol Vis. 2012;18:1478-83
pubmed: 22736939
Arch Ophthalmol. 2010 Jun;128(6):772-8
pubmed: 20547956
Nature. 1990 Jan 25;343(6256):364-6
pubmed: 2137202
Invest Ophthalmol Vis Sci. 2006 Jul;47(7):3052-64
pubmed: 16799052
Trends Mol Med. 2005 Apr;11(4):177-85
pubmed: 15823756
Proc Natl Acad Sci U S A. 1991 Oct 15;88(20):9370-4
pubmed: 1833777
Am J Hum Genet. 1990 Dec;47(6):941-5
pubmed: 2239971
Proc Natl Acad Sci U S A. 1991 Aug 1;88(15):6481-5
pubmed: 1862076
Invest Ophthalmol Vis Sci. 1993 Apr;34(5):1659-76
pubmed: 8473105
Acta Ophthalmol. 2015 Feb;93(1):e38-44
pubmed: 25408095